Crystagen

Crystagen is a classic thymus-derived short-peptide active nutritional product developed by a renowned Russian biological research institution. It belongs to the peptide regulation system led by renowned biologist Vladimir Havisen and has a broad research foundation and application scenarios in the global field of active peptide health maintenance. Its core active ingredient is the artificially synthesized short-peptide complex AC-6, composed of three precisely proportioned amino acids. The ingredient is of stable purity, and the formula contains no artificial redundant additives, allowing it to be used in conjunction with various health and nutritional products.

The core target of this product is the human thymus tissue. The thymus is a core gland that maintains the body's immune function. With age, long-term stress, adverse external environments, or significant physical damage, the thymus gradually declines in function, leading to a decrease in the body's immune defense capabilities. Crystagen, relying on the unique bioactivity of short peptides, can act on the gene expression process within immune cells. Through epigenetic regulation mechanisms, it helps the thymus tissue maintain a normal state, promotes the differentiation and proliferation of immune cells, optimizes the overall structure and activity of the immune cell community, and restructures the body's immune defense network.